+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are studying endometrial cancer, the most common gynecological cancer, focusing on the value of sentinel node biopsy SNB compared to no retroperitoneal node dissection. The study aims to assess if SNB affects patient recovery, morbidity, quality of life, healthcare costs, and disease-free survival. This Phase III randomized clinical trial addresses ongoing controversy over lymph node dissections benefits and risks in early-stage endometrial cancer treatment. Participants are randomly assigned to one of two groups one receiving total laparoscopic or robotic hysterectomy with bilateral salpingo-oophorectomy TH BSO combined with SNB using dye injections to identify sentinel lymph nodes, and the other receiving TH BSO without retroperitoneal node dissection. Some may omit ovary removal if under 45 with specific cancer features. The trial includes two stages the first with 444 patients focusing on recovery and quality of life, and the second with 316 patients evaluating disease-free survival over 4.5 years. During the study, participants undergo surgery followed by multiple assessments including quality of life questionnaires, clinical evaluations for lymphoedema and adverse events, imaging, and molecular profiling. Researchers measure recovery at 12 months and disease-free survival at 4.5 years, along with cost-effectiveness, treatment requirements, and recurrence patterns. The total participation duration extends up to 4.5 years to monitor long-term outcomes and safety.

Age: 18Years +FEMALEPhase 3
23 locations